Loading clinical trials...
Loading clinical trials...
This study in individuals with early Alzheimer's disease is designed to assess:(1) safety and tolerability (2) the capacity of ACC-001 and QS-21 adjuvant to reduce brain amyloid load as measured by po...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
Collaborators
NCT07214727 · Alzheimer's Disease
NCT07040904 · Mindfulness, Alzheimer's Disease Related Dementia
NCT05592678 · Alzheimer's Disease (AD), Dementia, and more
NCT07033494 · Early Alzheimer's Disease
NCT06584357 · Mild Cognitive Impairment, Alzheimer's Disease, and more
Banner Alzheimer's Institute
Phoenix, Arizona
Banner Good Samaritan Medical Center
Phoenix, Arizona
Banner Boswell Medical Center
Sun City, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions